These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36795658)

  • 1. COVID-19 Vaccination Coverage and Demographic Characteristics of Infants and Children Aged 6 Months-4 Years - United States, June 20-December 31, 2022.
    Murthy BP; Fast HE; Zell E; Murthy N; Meng L; Shaw L; Vogt T; Chatham-Stephens K; Santibanez TA; Gibbs-Scharf L; Harris LQ
    MMWR Morb Mortal Wkly Rep; 2023 Feb; 72(7):183-189. PubMed ID: 36795658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 Vaccination Coverage Among Adolescents Aged 12-17 Years - United States, December 14, 2020-July 31, 2021.
    Murthy BP; Zell E; Saelee R; Murthy N; Meng L; Meador S; Reed K; Shaw L; Gibbs-Scharf L; McNaghten AD; Patel A; Stokley S; Flores S; Yoder JS; Black CL; Harris LQ
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(35):1206-1213. PubMed ID: 34473680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties - United States, December 14, 2020-January 31, 2022.
    Saelee R; Zell E; Murthy BP; Castro-Roman P; Fast H; Meng L; Shaw L; Gibbs-Scharf L; Chorba T; Harris LQ; Murthy N
    MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(9):335-340. PubMed ID: 35239636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties - United States, December 14, 2020-April 10, 2021.
    Murthy BP; Sterrett N; Weller D; Zell E; Reynolds L; Toblin RL; Murthy N; Kriss J; Rose C; Cadwell B; Wang A; Ritchey MD; Gibbs-Scharf L; Qualters JR; Shaw L; Brookmeyer KA; Clayton H; Eke P; Adams L; Zajac J; Patel A; Fox K; Williams C; Stokley S; Flores S; Barbour KE; Harris LQ
    MMWR Morb Mortal Wkly Rep; 2021 May; 70(20):759-764. PubMed ID: 34014911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons - United States, December 14, 2020-February 14, 2021.
    Kriss JL; Reynolds LE; Wang A; Stokley S; Cole MM; Harris LQ; Shaw LK; Black CL; Singleton JA; Fitter DL; Rose DA; Ritchey MD; Toblin RL;
    MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(11):389-395. PubMed ID: 33735162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022.
    Fleming-Dutra KE; Wallace M; Moulia DL; Twentyman E; Roper LE; Hall E; Link-Gelles R; Godfrey M; Woodworth KR; Anderson TC; Rubis AB; Shanley E; Jones JM; Morgan RL; Brooks O; Talbot HK; Lee GM; Bell BP; Daley M; Meyer S; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2022 Jul; 71(26):859-868. PubMed ID: 35771731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 Vaccine Provider Availability and Vaccination Coverage Among Children Aged 5-11 Years - United States, November 1, 2021-April 25, 2022.
    DeCuir J; Meng L; Pan Y; Vogt T; Chatham-Stevens K; Meador S; Shaw L; Black CL; Harris LQ
    MMWR Morb Mortal Wkly Rep; 2022 Jul; 71(26):847-851. PubMed ID: 35771688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5-11 Years - United States, October 12-January 1, 2023.
    Hause AM; Marquez P; Zhang B; Su JR; Myers TR; Gee J; Panchanathan SS; Thompson D; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2023 Jan; 72(2):39-43. PubMed ID: 36634021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Vaccination Coverage Among Pregnant Women During Pregnancy - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 8, 2021.
    Razzaghi H; Meghani M; Pingali C; Crane B; Naleway A; Weintraub E; Kenigsberg TA; Lamias MJ; Irving SA; Kauffman TL; Vesco KK; Daley MF; DeSilva M; Donahue J; Getahun D; Glenn S; Hambidge SJ; Jackson L; Lipkind HS; Nelson J; Zerbo O; Oduyebo T; Singleton JA; Patel SA
    MMWR Morb Mortal Wkly Rep; 2021 Jun; 70(24):895-899. PubMed ID: 34138834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021.
    Zambrano LD; Newhams MM; Olson SM; Halasa NB; Price AM; Boom JA; Sahni LC; Kamidani S; Tarquinio KM; Maddux AB; Heidemann SM; Bhumbra SS; Bline KE; Nofziger RA; Hobbs CV; Bradford TT; Cvijanovich NZ; Irby K; Mack EH; Cullimore ML; Pannaraj PS; Kong M; Walker TC; Gertz SJ; Michelson KN; Cameron MA; Chiotos K; Maamari M; Schuster JE; Orzel AO; Patel MM; Campbell AP; Randolph AG;
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(2):52-58. PubMed ID: 35025852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.
    Self WH; Tenforde MW; Rhoads JP; Gaglani M; Ginde AA; Douin DJ; Olson SM; Talbot HK; Casey JD; Mohr NM; Zepeski A; McNeal T; Ghamande S; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Gong MN; Mohamed A; Henning DJ; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Exline MC; Halasa N; Chappell JD; Lauring AS; Grijalva CG; Rice TW; Jones ID; Stubblefield WB; Baughman A; Womack KN; Lindsell CJ; Hart KW; Zhu Y; Mills L; Lester SN; Stumpf MM; Naioti EA; Kobayashi M; Verani JR; Thornburg NJ; Patel MM;
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(38):1337-1343. PubMed ID: 34555004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3-5 Years - Increasing Community Access to Testing Program, United States, July 2022-February 2023.
    Fleming-Dutra KE; Ciesla AA; Roper LE; Smith ZR; Miller JD; Accorsi EK; Verani JR; Shang N; Derado G; Wiegand RE; Pilishvili T; Britton A; Link-Gelles R
    MMWR Morb Mortal Wkly Rep; 2023 Feb; 72(7):177-182. PubMed ID: 36795625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 Vaccination Coverage Among Insured Persons Aged ≥16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021.
    Pingali C; Meghani M; Razzaghi H; Lamias MJ; Weintraub E; Kenigsberg TA; Klein NP; Lewis N; Fireman B; Zerbo O; Bartlett J; Goddard K; Donahue J; Hanson K; Naleway A; Kharbanda EO; Yih WK; Nelson JC; Lewin BJ; Williams JTB; Glanz JM; Singleton JA; Patel SA
    MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(28):985-990. PubMed ID: 34264911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
    Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021.
    Tenforde MW; Patel MM; Gaglani M; Ginde AA; Douin DJ; Talbot HK; Casey JD; Mohr NM; Zepeski A; McNeal T; Ghamande S; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Gong MN; Mohamed A; Johnson NJ; Srinivasan V; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Duggal A; Wilson JG; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Exline MC; Botros M; Lauring AS; Shapiro NI; Halasa N; Chappell JD; Grijalva CG; Rice TW; Jones ID; Stubblefield WB; Baughman A; Womack KN; Rhoads JP; Lindsell CJ; Hart KW; Zhu Y; Naioti EA; Adams K; Lewis NM; Surie D; McMorrow ML; Self WH;
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):118-124. PubMed ID: 35085218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial and Ethnic Differences in COVID-19 Vaccination Coverage Among Children and Adolescents Aged 5-17 Years and Parental Intent to Vaccinate Their Children - National Immunization Survey-Child COVID Module, United States, December 2020-September 2022.
    Valier MR; Elam-Evans LD; Mu Y; Santibanez TA; Yankey D; Zhou T; Pingali C; Singleton JA
    MMWR Morb Mortal Wkly Rep; 2023 Jan; 72(1):1-8. PubMed ID: 36602930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years - United States, August 31-October 23, 2022.
    Hause AM; Marquez P; Zhang B; Myers TR; Gee J; Su JR; Blanc PG; Thomas A; Thompson D; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2022 Nov; 71(44):1401-1406. PubMed ID: 36327162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 Bivalent Booster Vaccination Coverage and Intent to Receive Booster Vaccination Among Adolescents and Adults - United States, November-December 2022.
    Lu PJ; Zhou T; Santibanez TA; Jain A; Black CL; Srivastav A; Hung MC; Kriss JL; Schorpp S; Yankey D; Sterrett N; Fast HE; Razzaghi H; Elam-Evans LD; Singleton JA
    MMWR Morb Mortal Wkly Rep; 2023 Feb; 72(7):190-198. PubMed ID: 36795677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examination of Adverse Reactions After COVID-19 Vaccination Among Patients With a History of Multisystem Inflammatory Syndrome in Children.
    Elias MD; Truong DT; Oster ME; Trachtenberg FL; Mu X; Jone PN; Mitchell EC; Dummer KB; Sexson Tejtel SK; Osakwe O; Thacker D; Su JA; Bradford TT; Burns KM; Campbell MJ; Connors TJ; D'Addese L; Forsha D; Frosch OH; Giglia TM; Goodell LR; Handler SS; Hasbani K; Hebson C; Krishnan A; Lang SM; McCrindle BW; McHugh KE; Morgan LM; Payne RM; Sabati A; Sagiv E; Sanil Y; Serrano F; Newburger JW; Dionne A;
    JAMA Netw Open; 2023 Jan; 6(1):e2248987. PubMed ID: 36595296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.
    Gargano JW; Wallace M; Hadler SC; Langley G; Su JR; Oster ME; Broder KR; Gee J; Weintraub E; Shimabukuro T; Scobie HM; Moulia D; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(27):977-982. PubMed ID: 34237049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.